Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma. (Articolo in rivista)

Type
Label
  • Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma. (Articolo in rivista) (literal)
Anno
  • 2010-01-01T00:00:00+01:00 (literal)
Alternative label
  • Pedretti M, Verpelli C, Marlind J, Bertani G, Sala C, Neri D and Bello L (2010)
    Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma.
    in British Journal of Cancer
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Pedretti M, Verpelli C, Marlind J, Bertani G, Sala C, Neri D and Bello L (literal)
Pagina inizio
  • 827 (literal)
Pagina fine
  • 836 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 103 (literal)
Rivista
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH-Swiss Federal Institute of Technology Zurich, Wolfgang- ?? Pauli-Strasse 10, 8093 Zurich, Switzerland; ?? University of Milan, IRCCS Ospedale Maggiore, Via Francesco Sforza 35, 20122 Milan, Italy (literal)
Titolo
  • Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma. (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
data.CNR.it